77 related articles for article (PubMed ID: 16128207)
1. [Primary HIV-1 infection in Zurich: 2002-2004].
Aceto L; Karrer U; Grube Ch; Oberholzer R; Hasse B; Presterl E; Böni J; Kuster H; Trkola A; Weber R; Günthard HF
Praxis (Bern 1994); 2005 Aug; 94(32):1199-205. PubMed ID: 16128207
[TBL] [Abstract][Full Text] [Related]
2. Frequency and Spectrum of Unexpected Clinical Manifestations of Primary HIV-1 Infection.
Braun DL; Kouyos RD; Balmer B; Grube C; Weber R; Günthard HF
Clin Infect Dis; 2015 Sep; 61(6):1013-21. PubMed ID: 25991469
[TBL] [Abstract][Full Text] [Related]
3. Social meets molecular: Combining phylogenetic and latent class analyses to understand HIV-1 transmission in Switzerland.
Avila D; Keiser O; Egger M; Kouyos R; Böni J; Yerly S; Klimkait T; Vernazza PL; Aubert V; Rauch A; Bonhoeffer S; Günthard HF; Stadler T; Spycher BD;
Am J Epidemiol; 2014 Jun; 179(12):1514-25. PubMed ID: 24821749
[TBL] [Abstract][Full Text] [Related]
4. Infrequent transmission of HIV-1 drug-resistant variants.
Yerly S; Jost S; Telenti A; Flepp M; Kaiser L; Chave JP; Vernazza P; Battegay M; Furrer H; Chanzy B; Burgisser P; Rickenbach M; Gebhardt M; Bernard MC; Perneger T; Hirschel B; Perrin L;
Antivir Ther; 2004 Jun; 9(3):375-84. PubMed ID: 15259900
[TBL] [Abstract][Full Text] [Related]
5. [Chronic hepatitis B and C in HIV-infected patients].
Opravil M; Hunziker R; Lüthy R; Grob PJ
Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
[TBL] [Abstract][Full Text] [Related]
6. Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy.
Fox J; Dustan S; McClure M; Weber J; Fidler S
HIV Med; 2006 Oct; 7(7):477-83. PubMed ID: 16925735
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of AIDS and HIV infection in Costa Rica.
Elizondo J; Shultz JM; Baum MK; Herrera G
Bull Pan Am Health Organ; 1993; 27(2):145-50. PubMed ID: 8339112
[TBL] [Abstract][Full Text] [Related]
8. Implementation of an Italian multicentric care network for early HIV infection diagnosis: 1999-2001 report.
Capiluppi B; Saracco A; Gianotti N; Mussini C; Butini L; Tomasoni L; De Gennaro M; Rizzolo L; Monolo G; Cargnel A; Moioli C; Arici C; Portelli V; Rizzardini G; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):73-8. PubMed ID: 12003179
[TBL] [Abstract][Full Text] [Related]
9. Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland North State of Tocantins, Brazil.
Carvalho BC; Cardoso LP; Damasceno S; Stefani MM
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1081-7. PubMed ID: 21417758
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.
Kouyos RD; von Wyl V; Yerly S; Böni J; Taffé P; Shah C; Bürgisser P; Klimkait T; Weber R; Hirschel B; Cavassini M; Furrer H; Battegay M; Vernazza PL; Bernasconi E; Rickenbach M; Ledergerber B; Bonhoeffer S; Günthard HF
J Infect Dis; 2010 May; 201(10):1488-97. PubMed ID: 20384495
[TBL] [Abstract][Full Text] [Related]
11. Subtype CRF01_AE dominate the sexually transmitted human immunodeficiency virus type 1 epidemic in Guangxi, China.
Li L; Chen L; Liang S; Liu W; Li T; Liu Y; Li H; Bao Z; Wang X; Li J
J Med Virol; 2013 Mar; 85(3):388-95. PubMed ID: 23341369
[TBL] [Abstract][Full Text] [Related]
12. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
Yerly S; von Wyl V; Ledergerber B; Böni J; Schüpbach J; Bürgisser P; Klimkait T; Rickenbach M; Kaiser L; Günthard HF; Perrin L;
AIDS; 2007 Oct; 21(16):2223-9. PubMed ID: 18090050
[TBL] [Abstract][Full Text] [Related]
13. Cohort profile: the Swiss HIV Cohort study.
; Schoeni-Affolter F; Ledergerber B; Rickenbach M; Rudin C; Günthard HF; Telenti A; Furrer H; Yerly S; Francioli P
Int J Epidemiol; 2010 Oct; 39(5):1179-89. PubMed ID: 19948780
[No Abstract] [Full Text] [Related]
14. High rates of transmitted drug resistance among newly-diagnosed antiretroviral naïve HIV patients in Northern Greece, data from 2009-2011.
Skoura L; Metallidis S; Pilalas D; Kourelis A; Margariti A; Papadimitriou E; Antoniadou ZA; Chrysanthidis T; Tsachouridou O; Kollaras P; Nikolaidis P; Malisiovas N
Clin Microbiol Infect; 2013 Mar; 19(3):E169-72. PubMed ID: 23331664
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of HIV-1 infection in Victoria. The Victorian Collaborative Group on HIV and AIDS Surveillance (VCGHAS).
Gertig D; Crofts N; Stevenson E; Breschkin A
Med J Aust; 1993 Jan; 158(1):17-20. PubMed ID: 8417284
[TBL] [Abstract][Full Text] [Related]
16. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
17. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
18. Horizontal versus vertical transmission of human immunodeficiency virus type 1 (HIV-1). Experience from southwestern Saudi Arabia.
al-Nozha MM; al-Frayh AR; al-Nasser M; Ramia S
Trop Geogr Med; 1995; 47(6):293-5. PubMed ID: 8650743
[TBL] [Abstract][Full Text] [Related]
19. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
20. Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007.
Brennan CA; Yamaguchi J; Devare SG; Foster GA; Stramer SL
Transfusion; 2010 Dec; 50(12):2707-12. PubMed ID: 20576010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
